AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY(英文缩写 AM J CLIN DERMATOL),ISSN 1175-0561,eISSN 1179-1888 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-21 至 2026-09-21，按本站收录文献的发表日期统计。
指标来源：jcr_cas_ifqb
期刊简介
暂无简介。
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 6.233 | Q1 |
| 2022 | 7.300 | Q1 |
| 2023 | 8.600 | Q1 |
| 2024 | 8.800 | Q1 |
| 2025 | 11.400 | Q1 |
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY 最新收录文献
※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。
-
2. Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.
PMID:作者:日期:2026-09-01Deucravacitinib, an oral, selective, tyrosine kinase 2 inhibitor, is approved for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy and for adults with active psoriatic arthritis. We evaluated deucravacitinib safety and efficacy over 5 years in the phase 3 POETY…
-
3. Systemic Comorbidities of Keloid and Hypertrophic Scars: A Phenome-Wide Association Study in a Multiethnic U.S. Pediatric Cohort.
3. 瘢痕疙瘩和增生性瘢痕的系统性共病：美国多民族儿科队列中的泛表型关联研究PMID:作者:日期:2026-09-01Excessive scarring (ES), including keloids and hypertrophic scars, impairs function, appearance, and quality of life in children. Its pediatric comorbidity spectrum is not well defined, limiting anticipatory guidance and multidisciplinary care. This research aims to investigate comorbidities of ES i…
-
4. Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
PMID:作者:日期:2026-09-01Alopecia areata is an autoimmune disorder characterised by T-cell-mediated damage of hair follicles, resulting in non-scarring hair loss that can progress to complete scalp (alopecia totalis) or body hair loss (alopecia universalis). While long-term systemic options were historically limited, the em…
-
6. Is Acanthosis Nigricans a Marker for Metabolic Syndrome? A Systematic Review.
PMID:作者:日期:2026-09-01Certain skin conditions are proven indicators of underlying systemic disease. Specifically, acanthosis nigricans (AN) is commonly associated with type 2 diabetes and insulin resistance. However, AN may also be a marker of metabolic syndrome (MS). MS is linked to several health conditions leading to …
-
7. Shared Mechanistic Pathways in Bullous Pemphigoid, Chronic Spontaneous Urticaria, Prurigo Nodularis, and Chronic Prurigo of Unknown Origin: Implications for Targeted Therapies.
7. 大疱性天疱疮、慢性自发性荨麻疹、结节性痒疹和不明原因慢性痒疹的共同机制途径：对靶向治疗的影响PMID:作者:日期:2026-09-01Bullous pemphigoid, chronic spontaneous urticaria, prurigo nodularis, and chronic prurigo of unknown origin are distinct chronic skin diseases with a high disease burden and an ongoing need for safe and effective therapies. Advances in our understanding of disease mechanisms have highlighted converg…
-
8. The Role of Skin Surface pH in Age Associated Pruritus: Mechanistic and Clinical Insights.
PMID:作者:日期:2026-09-01Skin aging is characterized by progressive structural and biochemical changes that impair epidermal barrier function, alter the cutaneous microbiome, and predispose to chronic pruritus. Epidermal thinning, reduced lipid synthesis, and slowed barrier repair increase transepidermal water loss and vuln…
-
9. Updated Integrated Safety Analysis of Ritlecitinib up to ~ 5 Years in Patients with Alopecia Areata from the ALLEGRO Clinical Trial Program.
PMID:作者:日期:2026-09-01Ritlecitinib, an oral Janus kinase (JAK) 3/tyrosine kinase expressed in hepatocellular carcinoma (TEC) family kinase inhibitor, demonstrated safety in patients aged 12 years and older with alopecia areata (AA) in an initial integrated analysis of 4 clinical studies for up to 2 years. This updated in…
-
10. A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis.
PMID:作者:日期:2026-09-01Atopic dermatitis (AD) is a chronic inflammatory dermatosis requiring multifaceted treatment. Poor adherence to topical therapy hinders symptom management, highlighting the need to identify barriers influencing adherence among adults with AD. Identify factors influencing adherence to topical therapy…